EMA (European Medicines Authority) officials have launched a new clinical trial map aimed to provide access to the public for “patients and healthcare professionals with… Read More »EMA launches a new clinical trial map aimed at increasing access to clinical research studies in the European Union (EU).
Researchers based at the Singapore National Eye Centre, and the Ophthalmology and Visual Sciences, Duke-NUS Graduate Medical School, Singapore, have published a report showing clear… Read More »Clinical distinctions between EYS- and USH2A-associated Retinitis Pigmentosa (RP) provides important implications for diagnosis, counselling and clinical practice.
Evidence presented in the journal The Lancet (Lancet 2025; 405: 648–57) have reported substantial benefits with improved visual acuity and functional vision following a treatment… Read More »Evidence of rescue of vision with gene supplementation for young patients diagnosed with variants in AIPL1-LCA4.
A collaboration of 41 international clinical centres that manage patients affected with inherited retinal diseases (IRDs), supported by the US Foundation Fighting Blindness (FFB), have… Read More »Foundation Fighting Blindness (FFB) have presented genetic data on IRDs for almost 34,000 patients and families within international sites.
A systematic review and meta-analysis, performed by researchers at the School of Medicine, College of Medicine, Taipei Medical University, have shown a strong association between… Read More »Retinal vein occlusion (RVO) appears to associate with an increased risk of myocardial infarction for patients,
Researchers at the Department of Translational Medicine, University of Ferrara, Italy, and colleagues in the ERN-EYE Network, have published paper on the first study to… Read More »Real-world impacts of an observational study on X-linked retinitis pigmentosa (XLRP) patients’ experience, supported by the ERN-EYE Network.
Researchers at the Department of Ophthalmology, Seoul National University College of Medicine, South Korea, have conducted a study to evaluate the national incidence of rare… Read More »A nationwide study on the incidence of rare retinal diseases in South Korea reports 1.1M clinical records.
Researchers at the Casey Eye Institute, Oregon Health & Science University (OHSU), Portland, USA, have provided formal results of a Phase 1/2 study, published at… Read More »A phase 1/2 multi-centre study provides results for the treatment of XLRP, promising a Phase 2/3 study to progress in 2025.
Researchers at the Department of Ophthalmology, Ajou University School of Medicine, Suwon, Republic of Korea, have outlined an increasing future burden of depressive disorders, providing… Read More »An investigation of the association between Retinitis pigmentosa (RP) and depressive disorder, including a call for practical training and methods.
Clinical researchers at the Department of Ophthalmology, Bascom Palmer Eye Institute, in the University of Miami, Florida, have presented an update on clinical trial endpoints… Read More »An update of clinical trial endpoints provide a dynamic trial environment across a range of inherited retinal degenerations (IRDs).
